Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jill Slansky

Concepts (330)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cancer Vaccines
14
2021
160
2.690
Why?
Receptors, Antigen, T-Cell
15
2023
668
2.480
Why?
CD8-Positive T-Lymphocytes
19
2024
917
2.320
Why?
Antigens, Neoplasm
13
2023
271
2.000
Why?
T-Lymphocytes
14
2023
1982
1.810
Why?
Neoplasms
13
2023
2875
1.770
Why?
Lymphocytes, Tumor-Infiltrating
5
2023
154
1.690
Why?
Vaccines, Subunit
4
2013
53
1.110
Why?
Peptides
8
2023
995
0.920
Why?
T-Lymphocytes, Cytotoxic
7
2022
177
0.910
Why?
Granzymes
2
2024
49
0.910
Why?
Epitopes, T-Lymphocyte
6
2012
175
0.880
Why?
Mice, Inbred BALB C
18
2021
1253
0.730
Why?
Leukemia
1
2024
245
0.700
Why?
Immunotherapy
8
2021
653
0.690
Why?
Lymphocyte Activation
11
2019
1126
0.680
Why?
Tumor Escape
3
2019
49
0.660
Why?
Tumor Microenvironment
8
2026
732
0.640
Why?
Baculoviridae
3
2009
44
0.620
Why?
Antigen Presentation
6
2018
205
0.620
Why?
Neoplasms, Experimental
2
2021
173
0.620
Why?
Immunogenetic Phenomena
1
2019
7
0.590
Why?
Immunomodulation
1
2020
101
0.590
Why?
Peptide Library
4
2013
95
0.580
Why?
Epitopes
2
2020
485
0.560
Why?
Insecta
3
2009
74
0.560
Why?
Animals
49
2026
38058
0.560
Why?
Histocompatibility Antigens Class I
6
2019
202
0.550
Why?
Major Histocompatibility Complex
4
2008
229
0.540
Why?
H-2 Antigens
5
2008
111
0.530
Why?
Mice
35
2026
18339
0.520
Why?
Breast Neoplasms
5
2026
2452
0.490
Why?
Alternative Splicing
1
2019
247
0.490
Why?
Gene Expression Regulation, Neoplastic
4
2019
1455
0.460
Why?
Autoimmunity
2
2020
926
0.450
Why?
Neoplasm Proteins
2
2018
442
0.430
Why?
Vaccines
2
2010
389
0.430
Why?
Immune Tolerance
3
2025
379
0.420
Why?
Antigens
3
2019
347
0.420
Why?
Up-Regulation
3
2019
851
0.420
Why?
Colorectal Neoplasms
5
2019
845
0.420
Why?
Cytotoxicity, Immunologic
6
2024
223
0.410
Why?
Colonic Neoplasms
3
2012
259
0.380
Why?
CD4-Positive T-Lymphocytes
3
2019
1129
0.370
Why?
Allergy and Immunology
1
2013
42
0.370
Why?
Complementarity Determining Regions
1
2012
53
0.360
Why?
B-Lymphocytes
1
2017
876
0.350
Why?
Antigenic Variation
1
2011
11
0.350
Why?
Moloney murine leukemia virus
1
2011
13
0.350
Why?
Viral Envelope Proteins
1
2011
98
0.330
Why?
Cell Cycle Proteins
6
1997
628
0.310
Why?
Carrier Proteins
6
1997
737
0.310
Why?
B7-H1 Antigen
2
2025
241
0.310
Why?
Histocompatibility Antigens
2
2020
102
0.300
Why?
DNA-Binding Proteins
9
2018
1499
0.290
Why?
Receptors, Antigen, T-Cell, alpha-beta
2
2022
331
0.280
Why?
Carcinoma, Non-Small-Cell Lung
1
2017
1180
0.280
Why?
Mice, Transgenic
6
2023
2182
0.270
Why?
Tetrahydrofolate Dehydrogenase
4
1997
23
0.270
Why?
Autoimmune Diseases
1
2012
463
0.270
Why?
Inflammation
4
2020
2878
0.250
Why?
Cross Reactions
2
2020
130
0.250
Why?
Cell Line, Tumor
11
2026
3540
0.250
Why?
Vaccination
3
2010
1423
0.240
Why?
Liver Neoplasms
4
2020
780
0.230
Why?
Nuclear Envelope
1
2026
46
0.230
Why?
Lab-On-A-Chip Devices
1
2026
60
0.230
Why?
Heme
1
2026
89
0.230
Why?
Triple Negative Breast Neoplasms
2
2019
215
0.230
Why?
Lung Neoplasms
2
2017
2637
0.230
Why?
Flow Cytometry
6
2016
1173
0.220
Why?
Humans
38
2026
144759
0.220
Why?
Histocompatibility Antigens Class II
2
2003
364
0.220
Why?
Semaphorins
1
2025
37
0.220
Why?
Graft Rejection
2
2007
540
0.210
Why?
Mammary Glands, Animal
1
2025
128
0.210
Why?
Antigens, CD
3
2025
555
0.210
Why?
Transfection
2
2026
940
0.210
Why?
Disease Models, Animal
3
2021
4557
0.200
Why?
Listeria monocytogenes
3
2011
116
0.200
Why?
Lymphocyte Count
4
2017
164
0.190
Why?
Models, Biological
1
2010
1821
0.190
Why?
Amino Acid Substitution
2
2020
304
0.180
Why?
Transcription Factors
6
1997
1741
0.180
Why?
Female
24
2026
78271
0.170
Why?
DNA
4
2026
1463
0.170
Why?
Base Sequence
7
2016
2190
0.170
Why?
Histocompatibility Antigen H-2D
4
2022
20
0.170
Why?
Dendritic Cells
3
2014
499
0.170
Why?
Aging
2
2011
1966
0.170
Why?
Receptor-CD3 Complex, Antigen, T-Cell
1
2000
9
0.170
Why?
Heterografts
1
2021
143
0.160
Why?
Cytoreduction Surgical Procedures
1
2020
67
0.160
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2020
1953
0.150
Why?
Immune System
1
2021
179
0.150
Why?
Programmed Cell Death 1 Receptor
3
2019
264
0.150
Why?
Chemokines, CXC
1
2019
68
0.150
Why?
Bcl-2-Like Protein 11
1
2019
37
0.150
Why?
Chemotherapy, Adjuvant
1
2020
421
0.150
Why?
Nanotechnology
1
2020
126
0.150
Why?
Gene Editing
1
2020
93
0.150
Why?
Interleukin-12
1
2019
117
0.140
Why?
Oligopeptides
1
2000
269
0.140
Why?
Gene Transfer Techniques
1
2020
185
0.140
Why?
Calcineurin
1
2019
105
0.140
Why?
Mice, Knockout
5
2021
3121
0.140
Why?
CRISPR-Cas Systems
1
2020
170
0.140
Why?
Tryptophan Oxygenase
1
2018
33
0.140
Why?
Autoantigens
1
2021
429
0.140
Why?
Macrophages
1
2026
1511
0.140
Why?
Disease Susceptibility
1
2020
348
0.140
Why?
Mutation
5
2020
4089
0.140
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2019
89
0.140
Why?
Genetic Therapy
1
2020
313
0.130
Why?
Promoter Regions, Genetic
5
1997
1257
0.130
Why?
Cell Line
2
2016
2882
0.130
Why?
Neoadjuvant Therapy
1
2020
462
0.130
Why?
Histone Deacetylase Inhibitors
1
2019
220
0.130
Why?
Immunodominant Epitopes
2
2010
27
0.130
Why?
Antigen-Presenting Cells
1
2017
160
0.130
Why?
Tryptophan
1
2018
181
0.130
Why?
Genetic Engineering
2
2009
93
0.130
Why?
Protein Tyrosine Phosphatases
1
2018
167
0.130
Why?
Transcriptional Activation
2
2018
383
0.130
Why?
Oligonucleotide Array Sequence Analysis
2
2016
758
0.120
Why?
Antineoplastic Agents, Immunological
1
2019
199
0.120
Why?
Spodoptera
2
2021
40
0.120
Why?
Mononuclear Phagocyte System
1
2016
10
0.120
Why?
Ligands
4
2018
673
0.120
Why?
Emulsions
1
2016
57
0.120
Why?
Immunophenotyping
1
2017
322
0.120
Why?
High-Throughput Nucleotide Sequencing
2
2017
549
0.120
Why?
Sarcoidosis, Pulmonary
1
2017
95
0.120
Why?
Lymph Nodes
2
2016
502
0.110
Why?
Gene Expression Regulation
4
2022
2608
0.110
Why?
Phagocytes
1
2016
81
0.110
Why?
Cell Separation
1
2016
307
0.110
Why?
Papillomavirus Infections
1
2019
345
0.110
Why?
T-Lymphocyte Subsets
4
2007
415
0.110
Why?
Gene Expression Regulation, Enzymologic
2
1993
269
0.110
Why?
Lung
3
2017
4109
0.110
Why?
Bronchoalveolar Lavage Fluid
1
2017
636
0.110
Why?
Retinoblastoma-Binding Protein 1
6
1997
22
0.110
Why?
Interferon-gamma
5
2011
784
0.110
Why?
Polymerase Chain Reaction
2
2016
1054
0.100
Why?
Ovarian Neoplasms
1
2020
586
0.100
Why?
Head and Neck Neoplasms
1
2019
558
0.100
Why?
E2F Transcription Factors
6
1997
62
0.100
Why?
Transcription Factor DP1
5
1997
21
0.100
Why?
Gene Expression Profiling
2
2010
1782
0.090
Why?
Colorado
2
2013
4564
0.090
Why?
Prognosis
2
2020
4282
0.090
Why?
Molecular Sequence Data
8
2006
2930
0.090
Why?
T-Lymphocytes, Regulatory
3
2012
389
0.090
Why?
Enzyme-Linked Immunosorbent Assay
2
2012
851
0.090
Why?
Transcription, Genetic
3
1997
1496
0.080
Why?
Hemangiosarcoma
1
2010
23
0.080
Why?
Lymphoma, B-Cell
1
2012
132
0.080
Why?
Universities
1
2013
452
0.080
Why?
Carcinoma
1
2011
228
0.080
Why?
Research
1
2013
431
0.080
Why?
Down-Regulation
1
2011
627
0.070
Why?
Genes, MHC Class I
1
2009
36
0.070
Why?
Neovascularization, Pathologic
1
2010
286
0.070
Why?
Mice, Inbred C57BL
5
2019
5992
0.070
Why?
Cross-Priming
1
2008
16
0.070
Why?
CD11c Antigen
1
2008
40
0.070
Why?
E2F1 Transcription Factor
4
1997
68
0.070
Why?
Adjuvants, Immunologic
1
2009
245
0.070
Why?
Protein Conformation
2
2003
946
0.060
Why?
Xenograft Model Antitumor Assays
2
2021
928
0.060
Why?
Cell Culture Techniques
1
2009
375
0.060
Why?
Intramolecular Oxidoreductases
1
2006
66
0.060
Why?
Biomarkers
1
2017
4271
0.060
Why?
Hematopoietic Stem Cell Transplantation
2
2021
675
0.060
Why?
Bilirubin
1
2026
97
0.060
Why?
Heme Oxygenase-1
1
2026
74
0.060
Why?
Melanoma, Experimental
1
2006
108
0.060
Why?
RNA, Messenger
2
1994
2832
0.060
Why?
Drug Design
1
2006
173
0.060
Why?
DNA Primers
1
2006
512
0.060
Why?
Plasmids
1
2026
379
0.050
Why?
Aged, 80 and over
1
2017
8265
0.050
Why?
Amino Acid Sequence
5
2018
2155
0.050
Why?
G1 Phase
2
1996
66
0.050
Why?
S Phase
2
1996
80
0.050
Why?
Male
8
2020
72315
0.050
Why?
Antigens, Surface
2
2001
157
0.050
Why?
Clone Cells
2
2003
266
0.050
Why?
Cells, Cultured
1
2011
4154
0.050
Why?
Mice, SCID
2
2021
369
0.050
Why?
Liver Neoplasms, Experimental
1
2003
26
0.050
Why?
3T3 Cells
4
2003
156
0.050
Why?
Genes, erbB-2
1
2003
33
0.050
Why?
Cell Survival
1
2026
1098
0.050
Why?
Mammary Neoplasms, Experimental
1
2003
70
0.050
Why?
Transplantation Chimera
1
2002
56
0.050
Why?
Germ Cells
1
2022
66
0.050
Why?
Molecular Conformation
1
2022
148
0.040
Why?
Interleukin-2
1
2003
437
0.040
Why?
Transglutaminases
1
2022
159
0.040
Why?
Sf9 Cells
1
2021
11
0.040
Why?
Middle Aged
3
2020
35875
0.040
Why?
Bone Marrow Cells
1
2002
320
0.040
Why?
B7-1 Antigen
1
2001
55
0.040
Why?
Chimerism
1
2021
35
0.040
Why?
Lymphocyte Subsets
1
2021
83
0.040
Why?
Lymphoid Tissue
1
2021
80
0.040
Why?
Immunoglobulins
1
2001
160
0.040
Why?
Aged
2
2017
25913
0.040
Why?
Surface Plasmon Resonance
1
2000
89
0.040
Why?
Recombinant Proteins
1
2003
1370
0.040
Why?
Dogs
2
2012
437
0.040
Why?
Alanine
1
2000
171
0.040
Why?
Mice, Inbred NOD
1
2021
610
0.040
Why?
Cyclophosphamide
2
2011
266
0.040
Why?
Skin Neoplasms
1
2006
847
0.040
Why?
Paraparesis, Tropical Spastic
1
1998
4
0.040
Why?
Gene Products, tax
1
1998
15
0.040
Why?
Models, Molecular
1
2003
1618
0.030
Why?
Gene Knockdown Techniques
1
2019
336
0.030
Why?
Lymphocytic Choriomeningitis
1
1998
25
0.030
Why?
Receptors, Tumor Necrosis Factor, Member 25
1
2017
5
0.030
Why?
Antibodies, Monoclonal
1
2025
1519
0.030
Why?
Kynurenine
1
2018
114
0.030
Why?
Combined Modality Therapy
1
2020
1266
0.030
Why?
Mice, Nude
1
2019
682
0.030
Why?
Antigens, Viral
1
1998
182
0.030
Why?
HLA-DRB1 Chains
1
2017
109
0.030
Why?
Drug Delivery Systems
1
2020
380
0.030
Why?
HLA Antigens
1
2018
225
0.030
Why?
Folic Acid Antagonists
1
1996
8
0.030
Why?
Sp1 Transcription Factor
1
1996
25
0.030
Why?
Enzyme Induction
1
1996
88
0.030
Why?
High-Throughput Screening Assays
1
2018
175
0.030
Why?
Regulatory Sequences, Nucleic Acid
1
1996
96
0.030
Why?
Survival Rate
1
2020
2089
0.030
Why?
Gene Amplification
1
1996
120
0.030
Why?
Cadaver
1
2016
304
0.030
Why?
Clinical Trials as Topic
1
2020
1053
0.030
Why?
Integrin alpha Chains
1
2014
22
0.030
Why?
Interleukin-27
1
2014
13
0.030
Why?
Toll-Like Receptor 3
1
2014
28
0.030
Why?
Poly I-C
1
2014
57
0.030
Why?
CD11b Antigen
1
2014
60
0.030
Why?
Toll-Like Receptor 7
1
2014
43
0.030
Why?
Acute Disease
1
2017
1030
0.030
Why?
Cell Division
2
1993
766
0.030
Why?
DNA Replication
1
1996
251
0.030
Why?
Cell Cycle
2
1994
596
0.030
Why?
Culture Media, Serum-Free
1
1993
42
0.020
Why?
Nuclear Proteins
2
2001
748
0.020
Why?
Imidazoles
1
2014
254
0.020
Why?
Serum Response Factor
1
1993
33
0.020
Why?
Cloning, Molecular
3
2001
540
0.020
Why?
Phenotype
1
2021
3162
0.020
Why?
RNA Polymerase II
1
1996
351
0.020
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
2
2003
161
0.020
Why?
Antineoplastic Agents
1
2003
2194
0.020
Why?
Membrane Glycoproteins
1
2014
496
0.020
Why?
Antigens, Differentiation
1
2011
77
0.020
Why?
Antineoplastic Agents, Alkylating
1
2011
72
0.020
Why?
Disease Progression
1
2019
2847
0.020
Why?
Cytokines
1
2019
2061
0.020
Why?
Dimerization
2
2001
194
0.020
Why?
CTLA-4 Antigen
1
2011
104
0.020
Why?
Von Hippel-Lindau Tumor Suppressor Protein
1
2010
16
0.020
Why?
Follow-Up Studies
1
2020
5408
0.020
Why?
Proteomics
1
2018
1195
0.020
Why?
Statistics, Nonparametric
1
2011
427
0.020
Why?
Protein Biosynthesis
1
1993
458
0.020
Why?
ras Proteins
1
2010
150
0.020
Why?
Doxorubicin
1
2012
397
0.020
Why?
Analysis of Variance
1
2011
1306
0.020
Why?
Survival Analysis
1
2011
1382
0.020
Why?
DNA, Complementary
2
2001
276
0.020
Why?
Protein Binding
2
2006
2273
0.020
Why?
Vaccines, Attenuated
1
2007
129
0.020
Why?
Binding Sites
3
1997
1329
0.020
Why?
Peptide Fragments
2
2003
699
0.020
Why?
Injections, Intradermal
1
2006
11
0.020
Why?
Enterotoxins
1
2006
89
0.010
Why?
Neoplasm Transplantation
1
2006
251
0.010
Why?
Hepatitis
1
2006
43
0.010
Why?
Cell Adhesion
1
2006
455
0.010
Why?
Killer Cells, Natural
1
2007
467
0.010
Why?
Cytotoxicity Tests, Immunologic
1
2003
37
0.010
Why?
Growth Inhibitors
1
2003
39
0.010
Why?
Vaccines, DNA
1
2003
31
0.010
Why?
Adult
2
2017
40449
0.010
Why?
Peptide Mapping
1
2003
63
0.010
Why?
Cell Line, Transformed
1
2003
140
0.010
Why?
Lymphocyte Culture Test, Mixed
1
2002
51
0.010
Why?
Injections, Intravenous
1
2003
200
0.010
Why?
Adoptive Transfer
1
2003
198
0.010
Why?
Mammary Neoplasms, Animal
1
2002
34
0.010
Why?
Drug Synergism
1
2003
357
0.010
Why?
Mice, Inbred DBA
1
2002
187
0.010
Why?
Mice, Inbred Strains
1
2003
397
0.010
Why?
ZAP-70 Protein-Tyrosine Kinase
1
2001
10
0.010
Why?
Transplantation Immunology
1
2001
29
0.010
Why?
Transplantation, Homologous
1
2002
415
0.010
Why?
Programmed Cell Death 1 Ligand 2 Protein
1
2001
14
0.010
Why?
CD28 Antigens
1
2001
58
0.010
Why?
Tumor Cells, Cultured
1
2002
919
0.010
Why?
Gene Library
1
2001
126
0.010
Why?
Sequence Homology, Amino Acid
1
2001
396
0.010
Why?
Graft vs Host Disease
1
2002
264
0.010
Why?
Apoptosis Regulatory Proteins
1
2001
186
0.010
Why?
In Vitro Techniques
1
2001
1047
0.010
Why?
Genetic Vectors
1
2001
337
0.010
Why?
Image Cytometry
1
1998
12
0.010
Why?
HTLV-I Infections
1
1998
28
0.010
Why?
HLA-A2 Antigen
1
1998
35
0.010
Why?
Human T-lymphotropic virus 1
1
1998
32
0.010
Why?
Recombinant Fusion Proteins
1
2001
675
0.010
Why?
Immunity, Active
1
1998
8
0.010
Why?
Protein-Tyrosine Kinases
1
2001
433
0.010
Why?
E2F5 Transcription Factor
1
1997
2
0.010
Why?
E2F4 Transcription Factor
1
1997
6
0.010
Why?
Immunologic Memory
1
1998
366
0.010
Why?
HeLa Cells
1
1997
650
0.010
Why?
Proteins
1
2001
1021
0.010
Why?
Models, Genetic
1
1997
536
0.010
Why?
Rats
1
2003
5597
0.010
Why?
Genes
1
1994
226
0.010
Why?
Chromosome Mapping
1
1994
510
0.010
Why?
Molecular Weight
1
1992
327
0.010
Why?
Mutagenesis, Site-Directed
1
1992
381
0.010
Why?
Signal Transduction
1
2001
5226
0.000
Why?
Slansky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)